Rare is many. Rare is strong. Rare is proud. Rare Disease Day, 28 February 2021

Rare is many. Rare is strong. Rare is proud. Rare Disease Day, 28 February 2021

According to the European Union, a disease is considered rare if it affects no more than five in every 10,000 people. However, this captures an extraordinary range of conditions with an enormous variation in prevalence. Take Fabry disease, for example, which affects up to five in 10,000 people and compare it to the much rarer […]

Read More

Going virtual: highlights from ISMPP EU 2021

Going virtual: highlights from ISMPP EU 2021

This year’s European Meeting of ISMPP (International Society for Medical Publication Professionals) took place on 26–27 January 2021 and saw over 300 delegates attending entirely virtually. The theme was ‘collaboration, connectivity and change’ and sessions featured an array of panel discussions, roundtables, keynotes and poster presentations on many current hot topics in the medical publications […]

Read More

Getting started in medical communications: what’s it like to be an associate medical writer?

Getting started in medical communications: what’s it like to be an associate medical writer?

Leia, Hayley and Sam joined the Bioscript team as Associate Medical Writers in October 2019. Find out more about their experiences over the past year below. I started a Biochemistry BSc (Hons) degree at the University of Liverpool in 2010 and subsequently found myself naturally following the Master’s–PhD–postdoc route due to my love for science […]

Read More

The scientific communication platform: generating a clear, consistent and compelling product narrative

The scientific communication platform: generating a clear, consistent and compelling product narrative

An SCP provides the strategic basis for a product’s communication plan and, when designed effectively, will ensure that accurate, consistent language and referencing is used throughout all communication activities and by functional teams. For a new product, the ideal time to develop an SCP is during the late stages of Phase II trials, as it […]

Read More